Neuroprotection and Neurometabolic Diseases Laboratory (Wysés Lab), Brazil; Graduate Program in Biological Sciences: Biochemistry, Department of Biochemistry, ICBS, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
Neuroprotection and Neurometabolic Diseases Laboratory (Wysés Lab), Brazil; Graduate Program in Biological Sciences: Biochemistry, Department of Biochemistry, ICBS, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
Neurobiol Learn Mem. 2022 Jul;192:107637. doi: 10.1016/j.nlm.2022.107637. Epub 2022 May 19.
Methylphenidate (MPH) has been widely misused by children and adolescents who do not meet all diagnostic criteria for attention-deficit/hyperactivity disorder. Since it is not yet known whether MPH can be administered in childhood without consequences in adulthood, in the present study we proposed to investigate the effects of chronic early treatment with MPH after a long period of discontinuation. Wistar male rats were injected with MPH (2 mg/kg, intraperitoneally) or saline solution once daily from 15th to 44th day of life. Two months after the last MPH administration, we evaluated the animal's performances on a battery of behavior tests. We also tested Na,K-ATPase and acetylcholinesterase activities in prefrontal cortex and hippocampus, which may be associated with behavior. Rats treated with MPH during peri-adolescence show changes in exploratory behavior in adulthood in the open field but not in the elevated plus maze and light-dark transition tests. MPH-treated rats showed a lower latency to find the platform in the training phase, as well as a better performance in the test phase in the Morris water maze test. No differences were observed in the object recognition index and working memory. Acetylcholinesterase was increased in prefrontal cortex and hippocampus, while Na,K-ATPase was increased only in hippocampus. These findings provide additional evidence that early-life exposure to MPH can have complex effects in adulthood and new basis for understanding the behavioral and neurochemical consequences associated with chronic use of MPH during the development of central nervous system.
哌醋甲酯(MPH)已被广泛滥用于未达到注意力缺陷多动障碍所有诊断标准的儿童和青少年。由于目前尚不清楚在儿童时期使用 MPH 是否会在成年后产生不良后果,因此本研究拟探讨长期停药后慢性早期 MPH 治疗的影响。Wistar 雄性大鼠从第 15 天到第 44 天每天腹腔注射 MPH(2mg/kg)或生理盐水一次。最后一次 MPH 给药后 2 个月,我们评估了动物在一系列行为测试中的表现。我们还测试了前额叶皮层和海马中的 Na,K-ATP 酶和乙酰胆碱酯酶活性,这些可能与行为有关。青春期早期接受 MPH 治疗的大鼠在成年后在开阔场中表现出探索行为的变化,但在高架十字迷宫和明暗转换测试中则没有。MPH 处理的大鼠在训练阶段找到平台的潜伏期更短,在 Morris 水迷宫测试的测试阶段表现更好。物体识别指数和工作记忆没有差异。乙酰胆碱酯酶在前额叶皮层和海马中增加,而 Na,K-ATP 酶仅在海马中增加。这些发现为早期生活中接触 MPH 会对成年期产生复杂影响提供了额外证据,并为理解与中枢神经系统发育期间慢性使用 MPH 相关的行为和神经化学后果提供了新的依据。